June 10, 2026 article Antidotes for Anticoagulation Reversal New England Journal of Medicine DOI: 10.1056/nejmra2506021 OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 4 References 4 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Andexanet Alfa or Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Acute Major Bleeding: A Systematic Review and Meta-Analysis 2021 Critical Care Medicine review Medicine Atrial Fibrillation Management and Outcomes 60 citations Idarucizumab for dabigatran reversal: A systematic review and meta-analysis of indications and outcomes 2023 Thrombosis Research review Medicine Atrial Fibrillation Management and Outcomes Open access 29 citations A meta‐analysis of andexanet alfa and prothrombin complex concentrate in the treatment of factor Xa inhibitor–related major bleeding 2021 Research and Practice in Thrombosis and Haemostasis article Medicine Atrial Fibrillation Management and Outcomes Open access 23 citations 3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis 2023 Thrombosis and Haemostasis review Medicine Blood transfusion and management Open access 14 citations 4 results